Asset Management One’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Asset Management One’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-85,417	Closed	-$9.88M	–	1030
2023 Q3	$9.88M	Buy	85,417 +1,904	+2%	+$205K	0.04%	390
2023 Q2	$8.59M	Sell	83,513 -1,493	-2%	-$158K	0.04%	442
2023 Q1	$9.28M	Buy	85,006 +964	+1%	+$107K	0.04%	420
2022 Q4	$9.54M	Sell	84,042 -2,212	-3%	-$184K	0.05%	400
2022 Q3	$5.34M	Sell	86,254 -112	-0.1%	-$7.83K	0.03%	524
2022 Q2	$6.89M	Sell	86,366 -5,753	-6%	-$545K	0.03%	489
2022 Q1	$9.69M	Sell	92,119 -5,461	-6%	-$532K	0.04%	448
2021 Q4	$10.6M	Sell	97,580 -648	-0.7%	-$70.7K	0.04%	470
2021 Q3	$10.8M	Sell	98,228 -1,092	-1%	-$113K	0.04%	452
2021 Q2	$9.3M	Sell	99,320 -3,584	-3%	-$330K	0.03%	503
2021 Q1	$9.47M	Sell	102,904 -13,868	-12%	-$1.17M	0.04%	483
2020 Q4	$8.17M	Buy	116,772 +105,721	+957%	+$7.86M	0.03%	498
2020 Q3	$858K	Buy	+11,051	New	+$760K	﹤0.01%	851
2016 Q4	–	Sell	-355,446	Closed	-$6.32M	–	1330
2016 Q3	$6.32M	Sell	355,446 -47,621	-12%	-$930K	0.09%	241
2016 Q2	$6.75M	Sell	403,067 -57,169	-12%	-$925K	0.1%	220
2016 Q1	$7.37M	Buy	460,236 +127,290	+38%	+$2.23M	0.11%	203
2015 Q4	$7.41M	Buy	332,946 +8,926	+3%	+$174K	0.11%	215
2015 Q3	$5.45M	Buy	324,020 +237,635	+275%	+$7.51M	0.08%	300
2015 Q2	$2.88M	Buy	+86,385	New	+$2.64M	0.04%	528

Other funds holding HZNP

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

VWA

Valued Wealth Advisors Holladay, Utah $275M AUM 24.94% 1-Year Est. Return

FSWA

Financial Synergies Wealth Advisors Houston, Texas $1.18B AUM 31.41% 1-Year Est. Return

BCMLT

Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $683M AUM 22.58% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Asset Management One's HZNP Position: Q4 2023 in Review

Asset Management One sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 85,417 shares — an estimated $9.88M sold.

Asset Management One first reported a position in HZNP in Q2 2015 and held it in 19 quarters. The position peaked at $10.8M in Q3 2021. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

Asset Management One reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
Asset Management One sold 85,417 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $9.88M.
Asset Management One first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q2 2015 and held it in 19 quarters.
Asset Management One's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $10.8M in Q3 2021.
6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on Asset Management One's 13F filing for Q4 2023, filed 24 Jan 2024.